| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.4 |